BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33595894)

  • 1. Immunotherapy for Merkel cell carcinoma.
    Angeles CV; Sabel MS
    J Surg Oncol; 2021 Mar; 123(3):775-781. PubMed ID: 33595894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and immune targets for Merkel cell carcinoma therapy and prevention.
    Cohen L; Tsai KY
    Mol Carcinog; 2019 Sep; 58(9):1602-1611. PubMed ID: 31116890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
    Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
    Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts and approaches to merkel cell carcinoma.
    Babadzhanov M; Doudican N; Wilken R; Stevenson M; Pavlick A; Carucci J
    Arch Dermatol Res; 2021 Apr; 313(3):129-138. PubMed ID: 32666149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Merkel-cell carcinoma: the dawn of a new era.
    O'Brien T; Power DG
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30002209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary.
    Kok DL; Wang A; Xu W; Chua MST; Guminski A; Veness M; Howle J; Tothill R; Kichendasse G; Poulsen M; Sandhu S; Fogarty G
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):312-319. PubMed ID: 32757453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on Merkel Cell Carcinoma.
    Emge DA; Cardones AR
    Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Merkel Cell Carcinoma.
    Nagase K; Narisawa Y
    Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
    Colunga A; Pulliam T; Nghiem P
    Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune checkpoint inhibition in Merkel cell carcinoma].
    Terheyden P; Mohr A; Langan EA
    Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
    Vandeven N; Nghiem P
    Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
    Bhatia S; Afanasiev O; Nghiem P
    Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we treat Merkel cell carcinoma: within and beyond current guidelines.
    Park SY; Doolittle-Amieva C; Moshiri Y; Akaike T; Parvathaneni U; Bhatia S; Zaba LC; Nghiem P
    Future Oncol; 2021 Apr; 17(11):1363-1377. PubMed ID: 33511866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma.
    Samimi M
    Am J Clin Dermatol; 2019 Jun; 20(3):391-407. PubMed ID: 30784027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.
    Rubin KM; Hoffner B; Bullock AC
    Semin Oncol Nurs; 2019 Oct; 35(5):150924. PubMed ID: 31514991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.
    Miller NJ; Bhatia S; Parvathaneni U; Iyer JG; Nghiem P
    Curr Treat Options Oncol; 2013 Jun; 14(2):249-63. PubMed ID: 23436166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merkel Cell Carcinoma Therapeutic Update.
    Cassler NM; Merrill D; Bichakjian CK; Brownell I
    Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?
    Ricco G; Andrini E; Siepe G; Mosconi C; Ambrosini V; Ricci C; Casadei R; Campana D; Lamberti G
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.